| PAR Stock | | | 294.05 12.65 4.50% |
Par Drugs financial indicator trend analysis is much more than just breaking down Par Drugs And prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Par Drugs And is a good investment. Please check the relationship between Par Drugs Depreciation And Amortization and its Total Assets accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Par Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Depreciation And Amortization vs Total Assets
Depreciation And Amortization vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Par Drugs And Depreciation And Amortization account and
Total Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Par Drugs' Depreciation And Amortization and Total Assets is 0.72. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Total Assets in the same time period over historical financial statements of Par Drugs And, assuming nothing else is changed. The correlation between historical values of Par Drugs' Depreciation And Amortization and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Par Drugs And are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Depreciation And Amortization i.e., Par Drugs' Depreciation And Amortization and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.72 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.
Total Assets
Total assets refers to the total amount of Par Drugs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Par Drugs And books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Par Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Par Drugs And current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Par Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
As of November 23, 2024,
Selling General Administrative is expected to decline to about 11.4
M. In addition to that,
Tax Provision is expected to decline to about 29.1
M | 2021 | 2022 | 2023 | 2024 (projected) |
Total Revenue | 742.0M | 951.0M | 956.4M | 669.2M | Depreciation And Amortization | 32.8M | 32.3M | 34.4M | 33.2M |
Par Drugs fundamental ratios Correlations
Click cells to compare fundamentals
Par Drugs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Par Drugs fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Par Stock
Balance Sheet is a snapshot of the
financial position of Par Drugs And at a specified time, usually calculated after every quarter, six months, or one year. Par Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Par Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Par currently owns. An asset can also be divided into two categories, current and non-current.